1 May 2011Big Pharma
Life sciences in Europe: the key jurisdictions
In the past year or so, life sciences companies have outperformed the stock exchange significantly. Though it would be foolish to call this a boom time for the industry, investors know that there is money to be made in developing innovative biotech solutions.
